Event by Novo Nordisk Foundation Science Cluster

    Protein Signaling - from pathways to networks

    Protein signaling is the cells most important regulatory mechanism to appropriately respond to internal and external cues. This is afforded by a wealth of posttranslational modifications, which expands the functional diversity of the human proteome by several orders of magnitude. Most therapeutic drugs are directed against proteins, or are proteins themselves, and protein-related technologies promise to revolutionize our understanding of the complex wiring of biological systems. This meeting will bring together world-leading researchers in the area of protein signaling with a focus on protein-driven mechanisms that are relevant to physiology and disease. The meeting will also have a strong emphasis on the emerging single cell and single-molecule technologies as well as on the advances in proteomics, network biology and structural biology. Finally, an important focus will be bridging fundamental discoveries to clinical relevant applications.

    Read more
    30-04 Sep-Oct 2018


    Agnel Sfeir Skirball Institute of Biomolecular Medicine, USA
    Bernhard Kuster Technical University of Munich (TUM), Germany
    Christian von Mering University of Zurich, Switzerland
    Evangelia Petsalaki EMBL-EBI, United Kingdom
    Georgios Skiniotis Stanford University, USA
    Hongtao Yu UT Southwestern Medical Center, USA
    Ian David Hickson Center for Chromosome Stability, University of Copenhagen
    Ido Amit Weizmann Institute of Science, Israel
    Jan Ellenberg EMBL, Cell Biology and Biophysics, Germany
    Jiri Lukas Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Denmark
    Jonathan Weissman University of California, San Francisco, USA
    Kasper Lage Harvard Medical School / Massachusetts General Hospital, USA
    Lucas Pelkmans "Department of Molecular Life Sciences, University of Zurich, Switzerland
    Nancy Maizels University of Washington Medical School, USA
    Michael B. Yaffe Koch Institute for Integrative Cancer Research, USA
    Peijun Zhang Divison of Structural Biology, University of Oxford, United Kingdom
    Ruedi Aebersold ETH Zurich, Inst. f. Molekulare Systembiologie, Switzerland
    Steve Jackson Cancer Research UK Gurdon Institute, United Kingdom
    Thejn Brummelkamp Netherlands Cancer Institute, The Netherlands
    Tobias Meyer Stanford University, USA

    Thank you very much to all participants, who helped us to successfully carry out the 14th Copenhagen Bioscience Conference.

    Closed for abstract submission

    Click here for  programme: Programme-CBC14.pdf

    Practical information

    If you wish to attend this conference, you will need to submit an abstract.
    Abstract submission is closed now.

    SHORT TALKS: Some applicants will be invited to give a short talk during the conference based on their submitted abstract. Selected applicants will be notified in the end of June 2018.

    Abstract submission deadline: June 10, 2018

    Evaluation of incoming applications:  end of  June 2018

    Notifications to applicants:  27 June 2018

    Deadline for registration:11 July 2018

    The registration fee, accommodation and local costs for all approved applicants are covered by the Novo Nordisk Foundation. Only travel expenses to and from the conference venue  are at your own expense.

    For practical details, please click here

    Conference topics

    Conference topics

    Protein structure and function
    Protein signalling
    Proteomics and protein networks
    Translational protein research
    Single cell and single molecule biology
    Read more